SRIVASTAVA, Neelam
SRIVASTAVA, Neelam
Biomedico di Medicina Interna e Specialistica (attivo dal 01/01/2013 al 31/12/2018)
Dietary cholesterol and estrogen administration elevate brain apolipoprotein E in mice by different mechanisms
2008-01-01 Srivastava, N; Averna, M; Srivastava, RA
Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1)
2012-01-01 Harikrishnan LS;, Srivastava N; Kayser LE; Nirschl DS; Kumaragurubaran K; Roy A; Gupta A; Karmakar S; Karatt T; Mathur A; Burford NT; Chen J; Kong Y; Cvijic M; Cooper CB; Poss MA; Trainor GL; Wong TW
Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
2018-01-01 Srivastava, Neelam; Cefalu, Angelo B.; Averna, Maurizio; Srivastava, Rai A. K.
STUDIES ON FACTORS INFLUENCING HIGH-DENSITY LIPOPROTEIN FUNCTIONALITY AND REVERSE CHOLESTEROL TRANSPORT
Srivastava, N.
The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.
2010-01-01 Srivastava, N; Cefalu', AB; Noto, D; Schonfeld, G; Averna, M; Srivastava, RA
Understanding the Origins of Problem Geomagnetic Storms Associated with “Stealth” Coronal Mass Ejections
2021-11-01 Nitta N.V.; Mulligan T.; Kilpua E.K.J.; Lynch B.J.; Mierla M.; O'Kane J.; Pagano P.; Palmerio E.; Pomoell J.; Richardson I.R.; Rodriguez L.; Rouillard A.P.; Sinha S.; Srivastava N.; Talpeanu D.-C.; Yardley S.L.; Zhukov A.N.
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 1-gen-2008 | Dietary cholesterol and estrogen administration elevate brain apolipoprotein E in mice by different mechanisms | SRIVASTAVA, NeelamAVERNA, Maurizio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Srivastava, N; Averna, M; Srivastava, RA | |
| 1-gen-2012 | Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1) | SRIVASTAVA, Neelam + | 01 - Contributo in rivista::1.01 Articolo in rivista | Harikrishnan LS;, Srivastava N; Kayser LE; Nirschl DS; Kumaragurubaran K; Roy A; Gupta A; Karmakar S; Karatt T; Mathur A; Burford NT; Chen J; Kong Y; Cvijic M; Cooper CB; Poss MA; Trainor GL; Wong TW | |
| 1-gen-2018 | Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis | Srivastava, NeelamCefalu, Angelo B.Averna, Maurizio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Srivastava, Neelam; Cefalu, Angelo B.; Averna, Maurizio; Srivastava, Rai A. K. | |
| - | STUDIES ON FACTORS INFLUENCING HIGH-DENSITY LIPOPROTEIN FUNCTIONALITY AND REVERSE CHOLESTEROL TRANSPORT | SRIVASTAVA, Neelam | 04 - Tesi di dottorato::4.2 Tesi di dottorato | Srivastava, N. | |
| 1-gen-2010 | The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation. | SRIVASTAVA, NeelamCEFALU', Angelo BaldassareNoto, DAVERNA, Maurizio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Srivastava, N; Cefalu', AB; Noto, D; Schonfeld, G; Averna, M; Srivastava, RA | |
| 1-nov-2021 | Understanding the Origins of Problem Geomagnetic Storms Associated with “Stealth” Coronal Mass Ejections | Pagano P.Srivastava N. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Nitta N.V.; Mulligan T.; Kilpua E.K.J.; Lynch B.J.; Mierla M.; O'Kane J.; Pagano P.; Palmerio E.; Pomoell J.; Richardson I.R.; Rodriguez L.; Rouillard A.P.; Sinha S.; Srivastava N.; Talpeanu D.-C.; Yardley S.L.; Zhukov A.N. |